Versant Venture Management
Latest statistics and disclosures from Versant Venture Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are GLUE, LENZ, JBIO, CRSP, CTNM, and represent 98.49% of Versant Venture Management's stock portfolio.
- Reduced shares in these 3 stocks: GLUE (-$20M), Repare Therapeutics Ord, Adverum Biotechnologies.
- Sold out of its positions in Adverum Biotechnologies, Repare Therapeutics Ord.
- Versant Venture Management was a net seller of stock by $-27M.
- Versant Venture Management has $151M in assets under management (AUM), dropping by -28.90%.
- Central Index Key (CIK): 0001560009
Tip: Access up to 7 years of quarterly data
Positions held by Versant Venture Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 7 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Monte Rosa Therapeutics Common Stock (GLUE) | 45.5 | $69M | -22% | 4.4M | 15.68 |
|
| Lenz Therapeutics Common Stock (LENZ) | 28.1 | $43M | 2.7M | 16.00 |
|
|
| Jade Biosciences Common Stock (JBIO) | 15.6 | $24M | 1.5M | 15.43 |
|
|
| CRISPR Therapeutics Common Shares (CRSP) | 5.2 | $7.8M | 149k | 52.44 |
|
|
| Contineum Therapeutics Common Stock (CTNM) | 4.1 | $6.2M | 543k | 11.43 |
|
|
| Skye Bioscience Common Stock (SKYE) | 1.0 | $1.5M | 2.0M | 0.75 |
|
|
| Tempest Therapeutics Common Stock | 0.5 | $774k | 270k | 2.87 |
|
Past Filings by Versant Venture Management
SEC 13F filings are viewable for Versant Venture Management going back to 2014
- Versant Venture Management 2025 Q4 filed Feb. 12, 2026
- Versant Venture Management 2025 Q3 filed Nov. 10, 2025
- Versant Venture Management 2025 Q2 filed Aug. 11, 2025
- Versant Venture Management 2025 Q1 filed May 7, 2025
- Versant Venture Management 2024 Q4 filed Feb. 12, 2025
- Versant Venture Management 2024 Q3 filed Nov. 8, 2024
- Versant Venture Management 2024 Q2 filed Aug. 7, 2024
- Versant Venture Management 2024 Q1 filed May 3, 2024
- Versant Venture Management 2023 Q4 filed Feb. 8, 2024
- Versant Venture Management 2023 Q3 filed Nov. 3, 2023
- Versant Venture Management 2023 Q2 filed Aug. 9, 2023
- Versant Venture Management 2023 Q1 filed May 11, 2023
- Versant Venture Management 2022 Q4 filed Feb. 9, 2023
- Versant Venture Management 2022 Q3 filed Nov. 10, 2022
- Versant Venture Management 2022 Q2 filed Aug. 11, 2022
- Versant Venture Management 2022 Q1 filed May 10, 2022